ResearcherHokkaido UniversityActive in the last 2 years

Hiroki Niwa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-6289-7680; OpenAlex author ID A5102497509. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model. Co-author DOI 10.1038/s41417-024-00810-7 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kazuho Inoko · 1 shared paper, 2024 · strength 0.18
- Paper Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a… DOI 10.1038/s41417-024-00810-7 ↗
Toshiaki Shichinohe · 1 shared paper, 2024 · strength 0.18
- Paper Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a… DOI 10.1038/s41417-024-00810-7 ↗
Takahiro Tsuchikawa · 1 shared paper, 2024 · strength 0.18
- Paper Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a… DOI 10.1038/s41417-024-00810-7 ↗
Toru Nakamura · 1 shared paper, 2024 · strength 0.18
- Paper Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a… DOI 10.1038/s41417-024-00810-7 ↗
Satoshi Hirano · 1 shared paper, 2024 · strength 0.18
- Paper Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a… DOI 10.1038/s41417-024-00810-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.